The information on this page is based on a number of underlying datasets, most of which are updated monthly. We maintain an update schedule which explains which version of each dataset we are currently relying on.
1 REAMS CLOSE is a midsized flat of 59m², built sometime between 1983 and 1990, which could now be worth an estimated £64,405. It was last sold for £18,250 in March 2000, which was around 12% below the average March 2000 flat price in the Boston local authority area. The most recent EPC inspection was February 2024, where the current energy rating was C, and the potential energy rating was B.
Land registry data shows one sale for 1 REAMS CLOSE since 1st January 1995. The below table shows the price paid for the one sale, along with the average flat price in the Boston local authority area for the corresponding sale date. The average price is sourced from the Office for National Statistics' House Price Index (HPI).
| Date | Price | HPI Price | Variation from HPI |
|---|---|---|---|
2000 3 MAR | £18,250 | £20,692 | 12% below HPI |
1 REAMS CLOSE might now be worth an estimated £64,405.
This is based on house price inflation of 252.9%, between March 2000 and May 2026, for flats, in the Boston local authority area, as calculated by the Office for National Statistics and published in their UK House Price Index (HPI).
The 252.9% inflationary increase is applied to the most recent sale price for 1 REAMS CLOSE of £18,250 on 3rd March 2000. For the value to have increased from £18,250 to £64,405 over the 25 years and ten months to May 2026, the following assumptions must hold true:
1 REAMS CLOSE is 59m² according to the EPC inspection conducted in February 2024. This puts it in the smallest 50% of flats in Boston, based on EPC data. 44% of flats are smaller than 1 REAMS CLOSE, and 53% of flats are larger. Note that EPC data is not available for all properties in Boston.
1 REAMS CLOSE sits on a plot of roughly 0.218 of an acre, or 883m².
1 REAMS CLOSE is located in FISHTOFT, in the PE21 postcode district.
Most recent sales first: